Meridian's clean third cohort collides with the file it won't open

The third cohort's charts read like a recruiter's dream. One hundred thirty-nine paid recipients, thirty days on Meridian's accelerated longevity protocol, no adverse events logged. The second cohort, an identical hundred thirty-nine, went home with clean markers and nothing sealed behind them. On any honest ward that's a good month.

(Good months are what you should be suspicious of. I'll get to that.)

The chart tells a different story about the fourth page. Nine of them, actually — the medical record of a retired desalination engineer from the first cohort of a hundred forty, who ran a fever of unexplained origin that resolved and has, by every account offered here, stayed resolved. Earth's longevity therapy board has asked to see those nine pages four times. Four times the Meridian directorate has said no, most recently while offering to open nearly everything else.

That everything-else is now the substance of a joint-audit framework, drafted this week by negotiators who have finally agreed on the shape of their disagreement. Under the draft, Earthside inspectors would examine aggregate outcome data for all three cohorts — markers, event logs, dosing — held in a shared dataset owned by neither party and audited by both. The one sealed file stays sealed.

"You can verify a population without undressing a patient," a directorate health officer told me, declining to be named because the framework is unsigned. "The aggregate is the evidence. One transient fever, resolved, is a footnote, not a finding."

Earth's board isn't convinced the colony gets to decide which pages are footnotes. "We have never been permitted to examine this therapy," said Dr. Aris Venn, who sits on the board that keeps requesting the file. "A dataset curated by the seller, with the one anomalous case withheld, is not an audit. It's a brochure with citations."

Here's the clinical question sitting underneath the sovereignty one. A fever of unexplained origin in cohort one is either noise — the kind of thing that happens to a hundred forty aging bodies no matter what you inject them with — or it's signal, an early adverse event the protocol would rather not name. From the aggregate alone you can't tell the difference. That's exactly what the nine pages would settle, and exactly why they matter to the marketing.

Because the marketing is on a schedule. The fourth charter sold its last berth weeks ago — a hundred thirty-nine more paying passengers — and departs in sixty-one days. They booked before the fever file became a diplomatic object, and they will arrive whether or not the joint audit is signed. The desperate keep voting with their transfer windows. The calendar doesn't wait for consensus, and it certainly doesn't wait for an audit.

Whether sealing the file protects the engineer's privacy or protects the program's clean record is, at this table, the same nine pages. Both sides agree the framework has to be signed before the fourth cohort lands. Neither will say what happens to the aggregate if, once inspected, it turns out to need a footnote after all.